Tom Wilemon

October 29, 2020

Lovly to chair foundation’s scientific leadership board

Christine Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, has been named incoming chair of GO2 Foundation’s Scientific Leadership Board (SLB).

By Tom Wilemon
October 29, 2020

VUMC researchers selected for inaugural FDA-AACR fellowship

Henry Henderson III, PhD, and Justin Lo, MD, PhD, are members of the 2020-2021 inaugural class of FDA-AACR Oncology Educational Fellows.

By Tom Wilemon
October 21, 2020

Park named director of Hematology and Oncology at VICC

After serving as interim director since Jan. 1, Ben Ho Park, MD, PhD, Donna S. Hall Professor of Breast Cancer Research at Vanderbilt University Medical Center, has been named director of the Division of Hematology and Oncology.

By Tom Wilemon
October 15, 2020

Initiative seeks to extract cancer phenotypes from electronic health records

The National Cancer Institute (NCI) has funded the development of interactive visual tools that will allow researchers to extract cancer phenotypes from electronic medical records.

By Tom Wilemon
A childhood role model helped inspire Portia Thomas to pursue a career in medicine and research.
October 1, 2020

Diversity role model inspires career path

Portia Thomas grew up in Doerun, Georgia, a small, rural city named by pioneer hunters as a place with “a perfect doe run,” where the population has hovered around 800 people for the past 30 years. A childhood impression lifted her aspirations beyond her hometown and inspired her to pursue a career as a physician-scientist.

By Tom Wilemon
September 29, 2020

VICC receives ‘exceptional’ score with renewal as an NCI-Designated Comprehensive Cancer Center

Vanderbilt-Ingram Cancer Center (VICC) received an overall “exceptional” score for its research impact and excellence in patient care. This achievement merits renewed funding from the National Cancer Institute (NCI) and places it once again in a top group of NCI Comprehensive Cancer Centers.

By Tom Wilemon
September 24, 2020

VICC leading first global study of MDS/MPN overlap syndrome

Overlap syndromes are distinct blood cancers that present with features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN).
By Tom Wilemon
September 17, 2020

Chic Awearness Sept. 24 virtual event to focus on ovarian cancer research

Chic Awearness, in collaboration with the Vanderbilt-Ingram Cancer Center, will host a virtual event on Sept. 24 focusing on ovarian cancer research and its impact during COVID-19.
By Tom Wilemon
August 27, 2020

Vanderbilt-Ingram opens cancer center in Wilson County

Vanderbilt-Ingram Cancer Center at Wilson County is slated to open Aug. 31 with a full array of highly specialized services, including diagnostic assessments, medical oncology and radiation oncology.
By Tom Wilemon
August 26, 2020

Chang named Vanderbilt-Ingram Cancer Center chief surgical officer

Sam Chang, MD, MBA, has been named chief surgical officer at Vanderbilt-Ingram Cancer Center (VICC), a new leadership position responsible for advancing excellence in surgical care in cancer patients, expanding service locations, maximizing resource efficiencies and maintaining high-quality standards among other duties.
By Tom Wilemon
August 13, 2020

Newer targeted therapy prolongs life for lung cancer patients

Patients with ALK-positive non-small cell lung cancer treated with ensartinib fared better and lived longer than those who received crizotinib, according to results of a phase 3 study.
By Tom Wilemon
August 6, 2020

Study gauges specific site stomach cancer risks among ethnic groups

Non-white Americans, especially Asian Americans, are at disproportionately higher risk for gastric cancer compared to non-Hispanic white Americans. A new study breaks down this risk according to specific ethnicities and locations within the stomach.
By Tom Wilemon